|
Volumn 174, Issue 1, 2014, Pages 136-137
|
The institute of medicine report sodium intake in populations: Assessment of evidence summary of primary findings and implications for clinicians
a,b,c |
Author keywords
[No Author keywords available]
|
Indexed keywords
FUROSEMIDE;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR EFFECT;
CARDIOVASCULAR RISK;
CHRONIC KIDNEY DISEASE;
CLINICAL ASSESSMENT;
CLINICAL PRACTICE;
CONGESTIVE HEART FAILURE;
DIABETES MELLITUS;
DRUG EFFECT;
FLUID INTAKE;
HEART EJECTION FRACTION;
HUMAN;
HYPERTENSION;
INSTITUTE OF MEDICINE;
ORGANIZATION;
OUTCOME ASSESSMENT;
PATIENT EDUCATION;
POPULATION;
PRIORITY JOURNAL;
PUBLIC HEALTH SERVICE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
SODIUM INTAKE;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS;
DIET, SODIUM-RESTRICTED;
EVIDENCE-BASED MEDICINE;
HEART FAILURE;
HUMANS;
HYPERTENSION;
INSTITUTE OF MEDICINE (U.S.);
RENAL INSUFFICIENCY, CHRONIC;
SODIUM, DIETARY;
UNITED STATES;
|
EID: 84892389365
PISSN: 21686106
EISSN: None
Source Type: Journal
DOI: 10.1001/jamainternmed.2013.11818 Document Type: Review |
Times cited : (21)
|
References (9)
|